The effectiveness of screening and treating Helicobacter pylori in the management of dyspepsia

被引:30
|
作者
Moayyedi, P [1 ]
Zilles, A [1 ]
Clough, M [1 ]
Hemingbrough, E [1 ]
Chalmers, DM [1 ]
Axon, ATR [1 ]
机构
[1] Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England
关键词
C-13-UBT; dyspepsia; Helicobacter pylori; open access endoscopy;
D O I
10.1097/00042737-199911000-00010
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aims (1) To investigate the effects of a Helicobacter pylori screening and treatment strategy on open access endoscopy referral rates in dyspeptic patients aged < 40 years. (2) To determine the effectiveness of an H. pylori screening and treatment strategy, compared with endoscopy, in reducing dyspeptic symptoms, and in the utilization of dyspepsia related health care in general practice. Subjects Subjects were dyspeptic patients aged < 40 years, who were not taking NSAIDs and were without sinister symptoms. Patients were referred by their general practitioners. Methods The proportion of endoscopies carried out in patients aged < 40 years during the 5 years before the introduction of a screening and treatment strategy was compared with the proportion 2 years afterwards, as determined in a retrospective audit Dyspepsia scores were obtained from unselected endoscopy patients and those who received a C-13-urea breath test (C-13-UBT) at their initial visit and 6 months later. The number of visits made by patients with dyspepsia to their GPs, as well as the number of prescriptions given for antisecretory drugs, during the 6 months before attending for investigation were compared, in the same patient groups, with the same variables during the 6 months after the investigation. Results There was a 37% reduction in open access endoscopies performed in patients aged < 40 years (95% CI, 34-40%) following the introduction of the 13C-UBT service. Six months after attending the C-13-UBT service there was a significant fall in dyspepsia score (15.5 +/- 7.4 to 7.2 +/- 7.0, P < 0.0001), general practice dyspepsia consultations (2.0 +/- 1.3 to 1.0 +/- 1.7, P < 0.0001), H-2 receptor antagonist prescription (14.2 +/- 32.6 tablets to 6.7 +/- 25.6 tablets, P = 0.006) but not proton pump inhibitor prescription (6.9 +/- 21.9 tablets to 7.2 +/- 27.6 tablets, P = 0.90). These changes were not significantly different from those found in the open access endoscopy control patients. Conclusions An H. pylori screening and treatment strategy reduces the endoscopy workload in young dyspeptic patients. This strategy appears to be as effective as endoscopy in reducing dyspepsia symptoms, dyspepsia consultation rates and the prescribing of anti-secretory drugs. Eur J Gastroenterol Hepatol 11:1245-1250 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:1245 / 1250
页数:6
相关论文
共 50 条
  • [11] Helicobacter pylori and dyspepsia
    Talley, NJ
    [J]. YALE JOURNAL OF BIOLOGY AND MEDICINE, 1999, 72 (2-3): : 145 - 151
  • [12] Dyspepsia and Helicobacter pylori
    Selgrad, Michael
    Kandulski, Arne
    Malfertheiner, Peter
    [J]. DIGESTIVE DISEASES, 2008, 26 (03) : 210 - 214
  • [13] Helicobacter pylori and dyspepsia
    Wu, J. C. Y.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 : 31 - 31
  • [14] PRO:: Endoscopy is necessary before treating Helicobacter pylori in patients with dyspepsia
    Sung, Joseph
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (03): : 473 - 474
  • [15] Management of dyspepsia and Helicobacter pylori in primary care in Ireland
    Collins, DN
    Kidney, GS
    O'Connor, HJ
    Oconnor, HJ
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A403 - A403
  • [16] Management of dyspepsia and Helicobacter pylori in general practice in Ireland
    Collins, DN
    Kidney, GF
    O'Connor, HJ
    [J]. GUT, 2001, 49 : A89 - A89
  • [17] Impact of Helicobacter pylori on the management of dyspepsia in primary care
    Bennett, K.
    Feely, J. .
    Thornton, O.
    Dobson, M.
    O'Morain, C. A.
    O'Connor, H. J.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (04) : 637 - 641
  • [18] Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
    Blum, AL
    Talley, NJ
    O'Moráin, C
    van Zanten, SV
    Labenz, J
    Stolte, M
    Louw, JA
    Stubberöd, A
    Theodórs, A
    Sundin, M
    Bolling-Sternevald, E
    Junghard, O
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (26): : 1875 - 1881
  • [19] Management of Helicobacter pylori - Positive patients with dyspepsia - Response
    Ofman, JJ
    Soll, AH
    Kahn, KL
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 127 (03) : 244 - 244